Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dalia Cohen

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|December 12, 2001
Isolation and characterization of a novel class II histone deacetylase, HDAC10Denise D Fischer, Richard Cai, Umesh Bhatia, et al.
The Journal of Biological Chemistry|May 14, 2010
Pro-tumorigenic effects of miR-31 loss in mesotheliomaSergey V Ivanov, Chandra M V Goparaju, Peter Lopez, et al.
Cancer Research|February 18, 2010
hsa-miR-29c* is linked to the prognosis of malignant pleural mesotheliomaHarvey I Pass, Chandra Goparaju, Sergey Ivanov, et al.
Cancer Research|October 7, 2010
hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapyEran Elyakim, Einat Sitbon, Alexander Faerman, et al.
Nature Biotechnology|July 19, 2005
Design of a genome-wide siRNA library using an artificial neural networkDieter Huesken, Joerg Lange, Craig Mickanin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2011
Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primaryGauri R Varadhachary, Yael Spector, James L Abbruzzese, et al.
Cancer Research|January 28, 2004
Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824Peter Atadja, Lin Gao, Paul Kwon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinomaDanit Lebanony, Hila Benjamin, Shlomit Gilad, et al.
The International Journal of Biochemistry & Cell Biology|July 13, 2010
Differential diagnosis of hepatocellular carcinoma from metastatic tumors in the liver using microRNA expressionIris Barshack, Eti Meiri, Shai Rosenwald, et al.
The Journal of Molecular Diagnostics : JMD|September 25, 2010
A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesotheliomaHila Benjamin, Danit Lebanony, Shai Rosenwald, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|December 12, 2001
Isolation and characterization of a novel class II histone deacetylase, HDAC10Denise D Fischer, Richard Cai, Umesh Bhatia, et al.
The Journal of Biological Chemistry|May 14, 2010
Pro-tumorigenic effects of miR-31 loss in mesotheliomaSergey V Ivanov, Chandra M V Goparaju, Peter Lopez, et al.
Cancer Research|February 18, 2010
hsa-miR-29c* is linked to the prognosis of malignant pleural mesotheliomaHarvey I Pass, Chandra Goparaju, Sergey Ivanov, et al.
Cancer Research|October 7, 2010
hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapyEran Elyakim, Einat Sitbon, Alexander Faerman, et al.
Nature Biotechnology|July 19, 2005
Design of a genome-wide siRNA library using an artificial neural networkDieter Huesken, Joerg Lange, Craig Mickanin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2011
Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primaryGauri R Varadhachary, Yael Spector, James L Abbruzzese, et al.
Cancer Research|January 28, 2004
Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824Peter Atadja, Lin Gao, Paul Kwon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinomaDanit Lebanony, Hila Benjamin, Shlomit Gilad, et al.
The International Journal of Biochemistry & Cell Biology|July 13, 2010
Differential diagnosis of hepatocellular carcinoma from metastatic tumors in the liver using microRNA expressionIris Barshack, Eti Meiri, Shai Rosenwald, et al.
The Journal of Molecular Diagnostics : JMD|September 25, 2010
A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesotheliomaHila Benjamin, Danit Lebanony, Shai Rosenwald, et al.
Pageof 3